Cargando…
Biomarkers of Hypoxic-Ischemic Encephalopathy in Newborns
As neonatal intensive care has evolved, the focus has shifted from improving mortality alone to an effort to improve both mortality and morbidity. The most frequent source of neonatal brain injury occurs as a result of hypoxic-ischemic injury. Hypoxic-ischemic injury occurs in about 2 of 1,000 full-...
Autores principales: | Douglas-Escobar, Martha, Weiss, Michael D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3486976/ https://www.ncbi.nlm.nih.gov/pubmed/23130015 http://dx.doi.org/10.3389/fneur.2012.00144 |
Ejemplares similares
-
An Assessment of Melatonin’s Therapeutic Value in the Hypoxic-Ischemic Encephalopathy of the Newborn
por: Cardinali, Daniel P.
Publicado: (2019) -
Biomarkers in newborns with hypoxic-ischemic encephalopathy treated with therapeutic hypothermia
por: Michniewicz, Barbara, et al.
Publicado: (2020) -
UCH-L1 and GFAP Serum Levels in Neonates with Hypoxic–Ischemic Encephalopathy: A Single Center Pilot Study
por: Douglas-Escobar, Martha V., et al.
Publicado: (2014) -
The Hypoxic Ischemic Encephalopathy Model of Perinatal Ischemia
por: Taniguchi, Hidetoshi, et al.
Publicado: (2008) -
The Function of the NMDA Receptor in Hypoxic-Ischemic Encephalopathy
por: Zhang, Xiaotong, et al.
Publicado: (2020)